11th Circ. Hands Catalyst Win In 'Orphan Drug' Case
By Nathan Hale · September 30, 2021, 9:54 PM EDT
Florida-based Catalyst Pharmaceuticals Inc. won a decision on Thursday in the Eleventh Circuit, which found that the U.S. Food and Drug Administration unlawfully infringed on an exclusivity period it awarded the...
To view the full article, register now.